Access Bio, Inc. (KOSDAQ: 950130)
South Korea
· Delayed Price · Currency is KRW
5,460.00
-110.00 (-1.97%)
Nov 15, 2024, 9:00 AM KST
Access Bio Revenue
Access Bio had revenue of 25.09B KRW in the quarter ending June 30, 2024, a decrease of -61.43%. This brings the company's revenue in the last twelve months to 101.33B, down -72.65% year-over-year. In the year 2023, Access Bio had annual revenue of 348.64B, down -66.28%.
Revenue (ttm)
101.33B
Revenue Growth
-72.65%
P/S Ratio
1.92
Revenue / Employee
1.00B
Employees
101
Market Cap
191.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 348.64B | -685.22B | -66.28% |
Dec 31, 2022 | 1,033.86B | 528.75B | 104.68% |
Dec 31, 2021 | 505.11B | 383.31B | 314.71% |
Dec 31, 2020 | 121.80B | 78.74B | 182.86% |
Dec 31, 2019 | 43.06B | 2.82B | 7.01% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition